CRNC
Cerence Inc.
CRNC has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over CRNC overall, supported by stronger modeled upside and stronger fundamentals.
CRNC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Strong | |
| Strong |
CRNC's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
CRNC PE Valuation
CRNC has no meaningful PE right now: it lost money over the past year.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK's PE is 7.5x, but its earnings don't support one, so it isn't a reliable read right now.
CRNC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Decline | |
| Decline | |
| Stable | |
| Limited | |
| High |
Analysts expect CRNC's earnings and revenue to decline, though with profitability holding steady.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
SNDK has the edge over CRNC on the outlook, with more favorable earnings and revenue expectations.
CRNC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.82 | — |
| Q2 2026 | -$0.31 | +$0.35 |
| Q1 2026 | -$0.40 | +$7.70 |
| Q4 2025 | $0.02 | +$15.24 |
| Q3 2025 | -$0.43 | +$13.69 |
| Q2 2025 | -$0.66 | +$13.26 |
| Q1 2025 | -$8.10 | -$1.27 |
| Q4 2024 | -$15.22 | -$14.40 |
| Q3 2024 | -$14.12 | -$12.72 |
CRNC is still losing money, but far less than before: $0.31 per share over the past year, against $15.22 at its worst in late 2024.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over CRNC in the latest year-over-year earnings comparison.
CRNC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $69.6M | +12% |
| Q1 2026 | $64.2M | -18% |
| Q4 2025 | $115.1M | +126% |
| Q3 2025 | $60.6M | +11% |
| Q2 2025 | $62.2M | -12% |
| Q1 2025 | $78M | +15% |
| Q4 2024 | $50.9M | -63% |
| Q3 2024 | $54.8M | -32% |
CRNC's revenue is recovering but still below its 2023 peak: $70M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 2.7% | +4.2 points |
| Q1 2026 | -3.8% | -26 points |
| Q4 2025 | 25% | +59 points |
| Q3 2025 | -2.9% | +32 points |
| Q2 2025 | -1.5% | +502 points |
| Q1 2025 | 22% | +412 points |
| Q4 2024 | -33% | -76 points |
| Q3 2024 | -35% | -40 points |
CRNC's operating margin was 2.7% last quarter, up 4.2 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK has the edge over CRNC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over CRNC on profitability, with a higher operating margin.
CRNC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $19.6M | +22% |
| Q1 2026 | $13.6M | +3.8% |
| Q4 2025 | $35.6M | +352% |
| Q3 2025 | $9.7M | +109% |
| Q2 2025 | $16.1M | +33% |
| Q1 2025 | $13.1M | +$13.9M |
| Q4 2024 | $7.9M | +$11.6M |
| Q3 2024 | $4.7M | -52% |
CRNC has the edge over SNDK on cash flow, with more consistent year-over-year improvement.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK generated $17.4B in free cash flow over the past year, more than ten times what it generated the year before.
CRNC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.8% | +845K shares |
| 1 year | +10% | +4.5M shares |
| 3 years | +18% | +7.4M shares |
| 5 years | +21% | +8.4M shares |
| Available history | +31% | +11.4M shares |
CRNC has 48M diluted shares, up 10% from a year ago, despite $8M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $52,000 |
| Q1 2026 | $13,000 |
| Q4 2025 | $7.5M |
| Q3 2025 | $180,000 |
| Q2 2025 | $29,000 |
| Q1 2025 | $802,000 |
| Q4 2024 | $1.4M |
| Q3 2024 | $8,000 |
CRNC spent $8M buying back its own shares over the past year, about four times what it spent the year before.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has the edge over CRNC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
CRNC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2019 | 0.0x | Very low |
CRNC has more cash than debt.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
CRNC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 31.1 | Neutral |
CRNC's weekly RSI is 45 (neutral) and its Stochastic is 31 (neutral).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
CRNC PE vs Technology Sector
| Metric | CRNC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CRNC has no meaningful PE right now: it lost money over the past year.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK is trading at 7.5x earnings, a 73% discount to the Technology sector's median of 28x, though its earnings don't support one.
CRNC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.27 | 1.3% below |
| 20 week MA | $8.62 | 5.3% below |
| 50 week MA | $9.28 | 12% below |
| 100 week MA | $9.87 | 17% below |
| 200 week MA | $12.9 | 37% below |
SNDK has stronger trend alignment. CRNC is above 0 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
CRNC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.0 | $105.1 | +401% |
| 2021 | $105.1 | $78.9 | -25% |
| 2022 | $78.9 | $18.6 | -76% |
| 2023 | $18.6 | $19.7 | +5.9% |
| 2024 | $19.7 | $8.49 | -57% |
| 2025 | $8.49 | $11.1 | +30% |
| 2026 YTD | $11.1 | $8.16 | -26% |
CRNC's yearly returns have swung widely, from +401% in 2020 to −76% in 2022. It's down 26% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over CRNC on returns for 2026, with the stronger performance.